ARTICLE | Company News
Aviron gains before PDUFA deadline
August 30, 2001 7:00 AM UTC
AVIR was up $0.49 to $23.40 on Thursday prior to Friday's Prescription Drug User Fee Act (PDUFA) deadline for its FluMist intranasal influenza vaccine. In July, the FDA's Vaccines and Related Biologic...